Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.62 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.43 |
| ▸ | CEL | P19835 | 2/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL454467 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1SLC18A3CELEPHX1 | |
| SCHEMBL10579794 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1SLC18A3CELEPHX1 | |
| SCHEMBL11503388 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1SLC18A3CELEPHX1 | |
| SCHEMBL8080519 | 0.97 | CYP1A2 (0.65) | CYP1A2SIGMAR1SLC18A3CELEPHX1 | |
| SCHEMBL9190697 | 0.93 | SIGMAR1 (0.70) | CYP1A2SIGMAR1CELEPHX1 | |
| SCHEMBL1207447 | 0.93 | CYP1A2 (0.60) | CYP1A2SIGMAR1SLC18A3CELEPHX1 | |
| SCHEMBL8023611 | 0.93 | SIGMAR1 (0.70) | CYP1A2SIGMAR1CELEPHX1 | |
| SCHEMBL5614191 | 0.93 | SIGMAR1 (0.70) | CYP1A2SIGMAR1CELEPHX1 | |
| SCHEMBL11653901 | 0.93 | SIGMAR1 (0.70) | CYP1A2SIGMAR1CELEPHX1 | |
| SCHEMBL7915243 | 0.90 | SIGMAR1 (0.75) | CYP1A2SIGMAR1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113122059-A | Preparation method of ink and quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-113122059-B | Preparation method of ink and quantum dot film | TCL科技集团股份有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-113122059-A | Preparation method of ink and quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | disclosed |
| US-20080300280-A1 | Cyanobenzene Compounds for Combating Animal Pests | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| EP-1956907-A2 | CYANOBENZENE COMPOUNDS FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007060220-A2 | CYANOBENZENE COMPOUNDS FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2007-05-31 | — | — | WO | disclosed |
| US-4849524-A | Process of preparing proline derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | disclosed |
| US-4775695-A | TREATMENT OF BRAIN INJURIES AND EDEMA | MERCK & CO., INC. (US) | 1988-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300280-A1 | Cyanobenzene Compounds for Combating Animal Pests | NR0B1, NR0B2, CBR1 | CYP1A2 149/4885SIGMAR1 114/4885SLC18A3 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.